Ionis Pharmaceuticals IONS Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's net income?
- Ionis Pharmaceuticals (IONS) reported net income of -$92.53M in Q1 2026.
- How has Ionis Pharmaceuticals's net income changed year-over-year?
- Ionis Pharmaceuticals's net income increased by 37.0% year-over-year, from -$146.94M to -$92.53M.
- What is the long-term trend for Ionis Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's net income has grown at a 91.1% compound annual growth rate (CAGR), from -$28.6M to -$381.39M.
- What does net income mean?
- The company's total profit or loss for the period after all expenses are paid.
- How do you interpret net income?
- Higher net income indicates strong profitability and operational efficiency, while negative values indicate a net loss.
- How does net income compare across companies?
- The primary metric for comparing bottom-line performance across all sectors.